Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss
1991

Effects of Proteolysis-Inducing Factors in Cancer Patients

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): J.E. Belizario, M. Katz, E. Chenker, I. Raw

Primary Institution: Centro de Biotecnologia, Instituto Butantan, Sdo Paulo, SP 05504, Brazil.

Hypothesis

Are muscle proteolysis-inducing factors involved in the weight loss of cancer patients?

Conclusion

The study found that bioactive factors in the plasma of cancer patients can enhance muscle protein breakdown, contributing to weight loss.

Supporting Evidence

  • Significant levels of bioactivity were detected in 25 of the 50 cancer samples.
  • No activity was found in 18 samples from healthy donors.
  • Indomethacin significantly inhibited muscle proteolysis induced by cancer plasma factors.
  • Neutralization with antibodies to IL-1 partially abrogated activity in some cancer samples.

Takeaway

Cancer patients can lose weight because their blood has special proteins that make their muscles break down faster.

Methodology

Blood samples were collected from cancer patients with significant weight loss, and the bioactivity of plasma proteins was assessed using isolated rat diaphragm muscles.

Limitations

The study did not determine the exact nature of the proteolysis-inducing factors.

Participant Demographics

32 male and 18 female cancer patients aged 13-83 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication